Although the cause-effect relationship between IDE and impaired insulin clearance in the setting of obesity has been extensively investigated in rodents, a recent review of the literature revealed that no conclusive information could be drawn about the impact of obesity on hepatic IDE levels and activity due to the use of different experimental models and the varying lengths and compositions of the dietary treatments [135]. This evidence concerns the gene INS and obesity disorder.